What a father’s or brother’s diagnosis means for you
Prostate cancer runs in families more than many men realize. Having a father or brother with the disease raises your own risk, and the effect grows with each affected relative and with how young they were at diagnosis. Shared genes explain part of it, and inherited changes such as BRCA2 explain a share of the most serious family clusters.
Three details from your family’s history matter most:
- Who was diagnosed. A father or brother counts more than a grandfather or uncle.
- How old they were. Diagnosis before 65 is the line the American Cancer Society uses to define higher risk.
- What kind of cancer. Metastatic or high-risk prostate cancer, and breast, ovarian or pancreatic cancer elsewhere in the family, point toward an inherited gene change.
If you do not know these details, ask. Many men learn that a relative’s “prostate problem” was cancer only when they finally ask about it.
Write down what you learn: who, at what age, what type, and how it was treated. Bring that note to every screening visit, because the same history can change the advice you get from a primary care doctor, a urologist or a testosterone clinic. Update it when a relative is newly diagnosed, since a second case in the family can move you into a higher-risk group. Brothers and sons benefit from the same list, so share it.
When PSA screening should start
The American Cancer Society sets the age to start a screening conversation by risk level:
| Your situation | ACS age to start the conversation |
|---|---|
| Average risk | 50 |
| Father or brother diagnosed before 65, or African American | 45 |
| More than one close relative diagnosed at an early age | 40 |
The ACS also suggests that men whose PSA is below 2.5 ng/mL may only need retesting every two years, while a PSA of 2.5 or higher calls for yearly screening. The U.S. Preventive Services Task Force frames screening at ages 55 to 69 as an individual decision and asks clinicians to weigh family history and race when helping men decide. Our page on when to start PSA screening compares the guidelines side by side.
A PSA test is a simple blood draw, but it is not specific to cancer. MedlinePlus lists an enlarged prostate, prostatitis, urinary tract infections and certain medicines among the causes of a high PSA, and notes that PSA levels go up and down, which is why trends over time are more useful than a single number. See the PSA blood test for men for preparation tips and what can raise PSA temporarily for the everyday causes of a false alarm.
When BRCA testing adds information
BRCA1 and BRCA2 are usually discussed in the context of breast and ovarian cancer, but they matter for men too. According to the National Cancer Institute, about 7 to 26 percent of men with a harmful BRCA1 change and 19 to 61 percent with a harmful BRCA2 change will develop prostate cancer by age 80, compared with about 10.6 percent of men in the general population. NCI also notes that prostate screening is particularly important for men with BRCA2 changes.
Testing makes the most sense when the family history points to an inherited cause. NCI’s list of factors includes a relative with a known BRCA change, Ashkenazi Jewish heritage, breast cancer at 50 or younger, and ovarian, male breast, pancreatic or metastatic or high-risk prostate cancer in the family. A father diagnosed with slow-growing prostate cancer at 78, with no other cancers in the family, is less likely to point to BRCA.
Ultimate Male’s Cancer Risk Insight Panel includes optional BRCA testing for men. A positive result affects screening age and frequency, and it matters for your siblings and children too, so a genetic counselor is a valuable partner in reading it. Our answer on the genetic risk panel for men explains what else that panel covers.
How family history shapes TRT decisions
Testosterone therapy and prostate safety are linked by careful monitoring rather than a blanket ban. The Endocrine Society’s testosterone therapy guideline recommends against starting testosterone without further urological evaluation in men with a PSA above 4 ng/mL, or above 3 ng/mL in men at high risk of prostate cancer. A father or brother with the disease puts you in that higher-risk group.
The guideline also suggests discussing prostate cancer risk and monitoring options with men aged 40 to 69 who are at increased risk, and recommends urology referral during treatment for a confirmed PSA rise of more than 1.4 ng/mL above baseline within the first 12 months, a confirmed PSA above 4.0 ng/mL, or an abnormal prostate exam. Our answers on whether TRT causes prostate cancer and on a high PSA before TRT go further.
Symptoms that should not wait for a screening schedule
Early prostate cancer usually causes no symptoms, which is the reason for screening. Some symptoms deserve a prompt visit rather than waiting for your next scheduled test: blood in the urine or semen, new bone pain in the back or hips, or urinary changes that are getting steadily worse. If you suddenly cannot urinate at all, go to the emergency room, because urinary retention needs same-day treatment.
How Ultimate Male handles a family history
Every man considering testosterone therapy at Ultimate Male starts with the TRT pre-screening panel, which includes PSA along with total testosterone, estradiol and a complete blood count. When your father or brother had prostate cancer, the provider reads that PSA against the stricter threshold, asks about the details of the diagnosis, and discusses whether optional BRCA testing would add useful information.
If the PSA or the history calls for it, you are referred to a urologist before any treatment decision. If you are cleared and choose testosterone therapy, PSA becomes part of regular follow-up labs. Draws are on site at San Gabriel or Downey with results in 24 to 48 hours. Start with a free 10-minute call, or see our full preventative blood testing menu. A consultation is an evaluation, never a promise of treatment.
